Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial
Top Cited Papers
- 1 January 2004
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 363 (9404) , 192-196
- https://doi.org/10.1016/s0140-6736(03)15324-x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathyAnnals of Neurology, 2001
- Fatigue in immune-mediated polyneuropathiesNeurology, 1999
- Epidemiological study of Guillain-Barre syndrome in south east EnglandJournal of Neurology, Neurosurgery & Psychiatry, 1998
- Treatment of Guillain‐Barré syndrome with high‐dose immune globulins combined with methylprednisolone: A pilot studyAnnals of Neurology, 1994
- Residual signs in severe Guillain-Barré syndrome: analysis of 57 patientsJournal of the Neurological Sciences, 1991
- Assessment of current diagnostic criteria for Guillain-Barr syndromeAnnals of Neurology, 1990
- Plasmapheresis and guillain‐barré syndrome: Analysis of prognostic factors and the effect of plasmapheresisAnnals of Neurology, 1988
- Efficiency of plasma exchange in Guillain‐Barré syndrome: Role of replacement fluidsAnnals of Neurology, 1987
- Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatmentAnnals of Neurology, 1982
- CONTROLLED TRIAL OF PREDNISOLONE IN ACUTE POLYNEUROPATHYThe Lancet, 1978